Drug of Abuse Testing Services Market Size Worth $4.08 Billion By 2028 | CAGR: 5.4%

The global drug of abuse testing services market size is expected to reach USD 4.08 billion by 2028 according to a new study by Polaris Market Research. The report “Drug of Abuse Testing Services Market Share, Size, Trends, Industry Analysis Report, By Product (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Others); By End-Use (Government, Private, Specialty Centers); By Regions; Segment Forecast, 2021 - 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Several governments across the globe are initiating strict policy guidelines to contain drug abuse cases in the market. In this direction, the National Drug Control Budget requested an amount of USD 34.6 billion in the last financial year across five areas such as law enforcement, prevention & testing, operation, treatment, and interdiction.

It includes a grant of USD 1.9 billion for the Substance Abuse and Mental Health Services Administration for funding of evidence-based prevention initiatives and services. Department of Defense also requested more than USD 1.2 billion to monitor and support drug interdiction to counter-drug operations on the U.S. soil.

Accessibility of the abuse testing services to the limited number of people with substance use across the market, with only being 1 in 7 cases being treated each year. However, in developed nations such as the U.S., there is a proper network and administration for reimbursement to treatment services to drug-related disorders. In line with this, the Centers for Medicare & Medicaid Services (CMS), in 2020, expanded its Medicare coverage to include medication-assisted treatment options in the opioid abuse testing and treatments scheduled.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/drugs-abuse-testing-services-market/request-for-sample

Drug abusers among hard-working employees risk the business, they are involved in. To eliminate those risks, employers need to conduct regular abuse testing programs in the market, however, this is being a privacy issue in many countries. There are several key legislations, which are protecting the individual’s testing privacy rights.

Market participants operating in the drug of abuse testing services industry include Quest Diagnostics, United States Drug Testing Laboratories (USDTL), Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Clinical Reference Laboratory (CRL), Inc., Cordant Health Solutions, DrugScan, Omega Laboratories, Inc., Legacy Medical Services, Psychemedics Corporation, Mayo Clinic Laboratories, Precision Diagnostics, Millennium Health, American Substance Abuse Professionals (ASAP), Inc., and LGC Group.

Polaris Market research has segmented the drug of abuse testing services market report on the basis of drug type, end-use, and region:

Drug of Abuse Testing Services, Drug Type Outlook (Revenue - USD Million, 2016 - 2028)

• Alcohol
• Cannabis/Marijuana
• Cocaine
• Opioids
• Amphetamine & Methamphetamine
• LSD
• Others

Drug of Abuse Testing Services, End Use Outlook (Revenue - USD Million, 2016 - 2028)

• Government
• Private
• Specialty Centers

Drug of Abuse Testing Services, by Regional Outlook (Revenue - USD Million, 2016 - 2028)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Central & South America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa